Community Pharmacy England (CPE) - News updates

The following price concessions granted in November 2025 have rolled over to December 2025: Drug Pack size November 2025 price concession Carbocisteine 375mg capsules 120 £2.95 Pyridostigmine bromide 60mg tablets 200 £15.79 Repaglinide 1mg tablets 90 £31.73 Please note any rolled over prices can be adjusted upwards if we receive reports from pharmacy owners to [...] The post Rolled over price concessions for December 2025 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (03/12/2025) confirmed the following final list of price concessions for November 2025. Drug Pack size Price concession Amiodarone 200mg tablets 28 £5.99 Aripiprazole 2.5mg tablets 28 £31.14 Carbocisteine 375mg capsules 120 £2.95 Estriol 0.01% vaginal cream with applicator 1 £47.05 Pyridostigmine bromide 60mg tablets 200 £15.79 Repaglinide [...] The post November 2025 Price Concessions – Final Update appeared first on Community Pharmacy England.

As part of our Funding & Reimbursement Shorts  series, Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video on disallowed items. Disallowed items are those that have not been passed for payment by the NHS Business Services Authority (NHSBSA). It is important that pharmacy teams understand what can be done avoid [...] The post Funding & Reimbursement Shorts: Disallowed items appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Rivastigmine 4.6mg/24hours transdermal patches Rivastigmine 9.5mg/24hours transdermal patches MSN/2025/062 Tier 3 – high impact Date of issue: 03/12/2025 Summary Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches are in limited supply until w/c 15 December 2025. Rivastigmine 13.3mg/24hours transdermal [...] The post Medicine Supply Notification: Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches appeared first on Community Pharmacy England.

Community Pharmacy England met in London on 19th and 20th November, with Committee members considering preparations for the next round of Community Pharmacy Contractual Framework (CPCF) negotiations, ongoing financial pressures, winter readiness and other important matters. Closing the sector’s longstanding funding gap and addressing operational pressures remain the central focus of the Committee. There has [...] The post Upcoming CPCF negotiations the focus at November meeting appeared first on Community Pharmacy England.

The NHSmail programme is being rebranded to NHS.net Connect. This change, announced previously, introduces a refreshed look and new features. Your existing NHS.net email address, login details, and helpdesk support will remain the same. Some NHS.net users will soon see a refreshed homepage and improved features designed to make communication across the NHS easier. The [...] The post NHSmail becoming NHS.net Connect: New Launchpad homepage coming soon appeared first on Community Pharmacy England.

In recent months, Community Pharmacy England has received a number of concerns about EPS pharmacy nominations and re-nominations without patient consent, and wishes to remind pharmacy owners of the relevant Terms of Service requirements and the importance of patient choice of nominated pharmacy. Terms of Service The Terms of Service provide that a pharmacy owner [...] The post Respecting Patient Choice for Pharmacy EPS Nominations appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (28/11/2025) confirmed the following list of price concessions for November 2025: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the Department. [...] The post November 2025 Price Concessions – 6th Update appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Cefalexin 125mg/5ml oral suspension sugar free and Cefalexin 250mg/5ml oral suspension sugar free is now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP077 Cefalexin 125mg/5ml oral suspension sugar free and SSP078 Cefalexin 250mg/5ml oral suspension [...] The post Expiry of SSP077 (Cefalexin 125mg/5ml oral suspension sugar free) & SSP078 (Cefalexin 250mg/5ml oral suspension sugar free) appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 December 2025. Generic drug name (dm+d descriptor) Brand and/or manufacturer Pack Size Special container Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose ampoules Teva UK Ltd 20 unit dose    [...] The post 6 products re-classified as special containers from December 2025 appeared first on Community Pharmacy England.